National Cancer Institute; Notice of Meetings, 62422-62423 [2011-25998]
Download as PDF
<![CDATA[
62422
Federal Register / Vol. 76, No. 195 / Friday, October 7, 2011 / Notices
TABLE A.12–1—ESTIMATES OF BURDEN HOURS FOR THREE YEARS
[Generic Study]
Number of
respondents
Type of respondents
Frequency of
response
2,000
1
Physicians ........................................................................................................
6,000
1
Health Professionals ........................................................................................
1,000
1
Researchers .....................................................................................................
1,000
1
Total ..........................................................................................................
jlentini on DSK4TPTVN1PROD with NOTICES
General Public .................................................................................................
11,500
........................
Average time
per response
(minutes/hour)
Request For Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the function of the
agency, including whether the
information will have practical utility;
(2) The accuracy of the agency’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) Ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
Ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the
Attention: NIH Desk Officer, Office of
Management and Budget at
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact Richard
P. Moser, Ph.D., Science of Research
and Technology Branch, Behavioral
Research Program, Division of Cancer
Control and Population Sciences,
National Cancer Institute/NIH, 6130
Executive Blvd., Rockville, MD 20892,
call non-toll-free number 301–496–0273
or e-mail your request, including your
address to: moserr@mail.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
VerDate Mar<15>2010
16:33 Oct 06, 2011
Jkt 226001
Dated: October 3, 2011.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2011–26043 Filed 10–6–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Cancellation of
Meeting
Notice is hereby given of the
cancellation of the Interagency Breast
Cancer and Environmental Research
Coordinating Committee, October 12,
2011, 1 p.m. to 3 p.m., NIEHS/National
Institutes of Health, Building 4401, East
Campus, 79 T.W. Alexander Drive,
Research Triangle Park, NC 27709
which was published in the Federal
Register on August 12, 2011, 76 FR
50234.
Dated: September 30, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–26000 Filed 10–6–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Frm 00087
Fmt 4703
Sfmt 4703
15/60
(0.25)
30/60
(0.5)
60/60
(1)
90/60
(1.5)
500
1,000
........................
6,000
3,000
1,500
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group, Clinical
Trials Review Committee.
Date: October 24–25, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Keary A Cope, Ph.D.,
Scientific Review Officer, Review
Branch/DERA, National Heart, Lung,
and Blood Institute, 6701 Rockledge
Drive, Room 7190, Bethesda, MD
20892–7924, 301–435–2222,
copeka@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: October 3, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–25999 Filed 10–6–11; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
PO 00000
Total burden
hours
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meetings
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
E:\FR\FM\07OCN1.SGM
07OCN1
jlentini on DSK4TPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 195 / Friday, October 7, 2011 / Notices
hereby given of meetings of the National
Cancer Institute Board of Scientific
Advisors.
The meetings will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Board of Scientific Advisors.
Date: November 6, 2011.
Time: 6:30 p.m. to 8:30 p.m.
Agenda: caBIG® Oversight Ad Hoc
Subcommittee Meeting.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Persons: John Czajkowski,
MPA, Deputy Director for Management,
OD, and Paulette S. Gray, PhD, Director,
DEA, National Cancer Institute, National
Institutes of Health, 31 Center Drive,
Rm. 11A48, Bethesda, MD 20892, 301–
435–2455; 301–496–5147, respectively,
john.czajkowski@nih.gov;
grayp@mail.nih.gov, respectively.
Name of Committee: National Cancer
Institute Board of Scientific Advisors.
Date: November 7, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: Director’s Report: Ongoing
and New Business; Reports of
Subcommittees, and Working Groups;
and Budget Presentations; Reports of
Special Initiatives; RFA and RFP
Concept Reviews; and Scientific
Presentations.
Place: National Institutes of Health,
Building 31, 31 Center Drive, 6th Floor,
Conference Rm. 10, Bethesda, MD
20892.
Contact Person: Paulette S. Gray, PhD,
Executive Secretary, Director, Division
of Extramural Activities, National
Cancer Institute, National Institutes of
Health, 6116 Executive Boulevard, 8th
Floor, Rm. 8001, Bethesda, MD 20892,
301–496–5147, grayp@mail.nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for
entrance onto the NIH campus. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors will be asked to show
one form of identification (for example,
a government-issued photo ID, driver’s
VerDate Mar<15>2010
16:33 Oct 06, 2011
Jkt 226001
license, or passport) and to state the
purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/bsa/
bsa.htm, where an agenda and any
additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: October 3, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–25998 Filed 10–6–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National
Institute on Deafness and Other
Communication Disorders, Special
Emphasis Panel, Clinical Trials.
Date: October 24, 2011.
Time: 9 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
6120 Executive Blvd., Rockville, MD
20852, (Telephone Conference Call).
Contact Person: Christine A.
Livingston, PhD, Scientific Review
Officer, Division of Extramural
Activities, National Institutes of Health/
NIDCD, 6120 Executive Blvd.—MSC
7180, Bethesda, MD 20892, (301) 496–
8683, livingsc@mail.nih.gov.
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
62423
Name of Committee: National
Institute on Deafness and Other
Communication Disorders, Special
Emphasis Panel, Review of Clinical
Trials.
Date: October 27, 2011.
Time: 11 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
6120 Executive Blvd., Rockville, MD
20852, (Telephone Conference Call).
Contact Person: Christine A.
Livingston, PhD, Scientific Review
Officer, Division of Extramural
Activities, National Institutes of Health/
NIDCD, 6120 Executive Blvd.—MSC
7180, Bethesda, MD 20892, (301) 496–
8683, livingsc@mail.nih.gov.
Name of Committee: National
Institute on Deafness and Other
Communication Disorders, Special
Emphasis Panel, Clinical Trials.
Date: October 31, 2011.
Time: 10 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
6120 Executive Blvd., Rockville, MD
20852, (Telephone Conference Call).
Contact Person: Christine A.
Livingston, PhD, Scientific Review
Officer, Division of Extramural
Activities, National Institutes of Health/
NIDCD, 6120 Executive Blvd.—MSC
7180, Bethesda, MD 0892, (301) 496–
8683, livingsc@mail.nih.gov.
Name of Committee: National
Institute on Deafness and Other
Communication Disorders, Special
Emphasis Panel, Clinical Trials.
Date: November 3, 2011.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
6120 Executive Blvd., Rockville, MD
20852, (Telephone Conference Call).
Contact Person: Melissa Stick, PhD,
MPH, Chief, Scientific Review Branch,
Scientific Review Branch, Division of
Extramural Activities, NIDCD/NIH, 6120
Executive Blvd., Bethesda, MD 20892,
301–496–8683.
Name of Committee: National
Institute on Deafness and Other
Communication Disorders, Special
Emphasis Panel R03, Hearing and
Balance.
Date: November 4, 2011.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
6120 Executive Blvd., Rockville, MD
20852, (Telephone Conference Call).
Contact Person: Christine A.
Livingston, PhD, Scientific Review
E:\FR\FM\07OCN1.SGM
07OCN1
]]>Agencies
[Federal Register Volume 76, Number 195 (Friday, October 7, 2011)]
[Notices]
[Pages 62422-62423]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-25998]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meetings
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
[[Page 62423]]
hereby given of meetings of the National Cancer Institute Board of
Scientific Advisors.
The meetings will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: National Cancer Institute Board of Scientific
Advisors.
Date: November 6, 2011.
Time: 6:30 p.m. to 8:30 p.m.
Agenda: caBIG[supreg] Oversight Ad Hoc Subcommittee Meeting.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Persons: John Czajkowski, MPA, Deputy Director for
Management, OD, and Paulette S. Gray, PhD, Director, DEA, National
Cancer Institute, National Institutes of Health, 31 Center Drive, Rm.
11A48, Bethesda, MD 20892, 301-435-2455; 301-496-5147, respectively,
john.czajkowski@nih.gov; grayp@mail.nih.gov, respectively.
Name of Committee: National Cancer Institute Board of Scientific
Advisors.
Date: November 7, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: Director's Report: Ongoing and New Business; Reports of
Subcommittees, and Working Groups; and Budget Presentations; Reports of
Special Initiatives; RFA and RFP Concept Reviews; and Scientific
Presentations.
Place: National Institutes of Health, Building 31, 31 Center Drive,
6th Floor, Conference Rm. 10, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, PhD, Executive Secretary,
Director, Division of Extramural Activities, National Cancer Institute,
National Institutes of Health, 6116 Executive Boulevard, 8th Floor, Rm.
8001, Bethesda, MD 20892, 301-496-5147, grayp@mail.nih.gov.
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one form
of identification (for example, a government-issued photo ID, driver's
license, or passport) and to state the purpose of their visit.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/bsa/bsa.htm, where an agenda
and any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: October 3, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-25998 Filed 10-6-11; 8:45 am]
BILLING CODE 4140-01-P
